Tadomon 25 mg tablete s produljenim oslobađanjem
Name | Tadomon 25 mg tablete s produljenim oslobađanjem |
---|---|
Marketing Authorisation Number | HR-H-427382092 |
Active Substance | tapentadoltartarat |
Composition | jedna tableta s produljenim oslobađanjem sadrži 25 mg tapentadola (u obliku tapentadoltartarata) |
Pharmaceutical Form | Tableta s produljenim oslobađanjem |
Manufacturer | Laboratorios Liconsa S.A., Azuqueca de Henares, Guadalajara, Španjolska G.L. Pharma GmbH, Lannach, Austrija |
Marketing Authorisation Holder | G.L. Pharma GmbH, Schlossplatz 1, Lannach, Austrija |
Marketing Authorisation Date | 22.03.2024 |
MA Period of Validity | 07.07.2027 |
Classification Number | UP/I-530-09/21-01/66 |
Registration Number | 381-12-01/70-24-18 |
Prescription | na recept |
Type of prescription | poseban recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | N02AX06 |
SmPC | download |
PL | download |
Public Assessment Report | download |